ASX - By Stock
|
AVR |
Re:
Ann: Application for quotation of securities - AVR
|
|
whitefox9
|
29 |
9.3K |
0 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
29
|
9.3K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
whitefox9
|
200 |
55K |
4 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
200
|
55K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Three ViV Patients Completed under Health Canada SAP
|
|
whitefox9
|
28 |
7.7K |
4 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
28
|
7.7K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
all will be revealed.
|
|
whitefox9
|
5 |
3.6K |
2 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
5
|
3.6K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Investor Presentation
|
|
whitefox9
|
66 |
20K |
8 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
66
|
20K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Dr interview from London Valves 2023
|
|
whitefox9
|
10 |
3.5K |
7 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
10
|
3.5K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial
|
|
whitefox9
|
74 |
23K |
11 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
74
|
23K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial
|
|
whitefox9
|
74 |
23K |
2 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
74
|
23K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Capital Raise
|
|
whitefox9
|
116 |
30K |
0 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
116
|
30K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Capital Raise
|
|
whitefox9
|
116 |
30K |
1 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
116
|
30K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
whitefox9
|
40 |
13K |
1 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
40
|
13K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
ozaki procedure
|
|
whitefox9
|
8 |
2.7K |
1 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
8
|
2.7K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Notification regarding unquoted securities - AVR
|
|
whitefox9
|
3 |
1.2K |
3 |
19/09/23 |
19/09/23 |
ASX - By Stock
|
3
|
1.2K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Anteris to Present at Cantor Healthcare Conference
|
|
whitefox9
|
73 |
26K |
9 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
73
|
26K
|
9
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Exceptional Results in Second Valve-in-Valve Case
|
|
whitefox9
|
42 |
12K |
2 |
14/08/23 |
14/08/23 |
ASX - By Stock
|
42
|
12K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Montefiore enrolls Patients in US Early Feasibility Study
|
|
whitefox9
|
28 |
7.9K |
5 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
28
|
7.9K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Notice of Extraordinary General Meeting/Proxy Form
|
|
whitefox9
|
42 |
12K |
17 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
42
|
12K
|
17
|
|
ASX - By Stock
|
AVR |
Re:
AVR CEO interview on Proactive Investors
|
|
whitefox9
|
27 |
7.4K |
0 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
27
|
7.4K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
AGM recording
|
|
whitefox9
|
19 |
6.2K |
10 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
19
|
6.2K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
Ann: AGM Chairman Address and CEO Presentation
|
|
whitefox9
|
27 |
10K |
8 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
27
|
10K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Ann: AGM Chairman Address and CEO Presentation
|
|
whitefox9
|
27 |
10K |
1 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
27
|
10K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Proactive vid
|
|
whitefox9
|
45 |
17K |
1 |
08/05/23 |
08/05/23 |
ASX - By Stock
|
45
|
17K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Becoming a substantial holder from MS
|
|
whitefox9
|
14 |
4.1K |
1 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
14
|
4.1K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Settlement of $35M Capital Raising Transaction
|
|
whitefox9
|
205 |
65K |
1 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
205
|
65K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
AVR Quarterly
|
|
whitefox9
|
3 |
1.3K |
0 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
3
|
1.3K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
3D printed heart valves
|
|
whitefox9
|
28 |
10K |
0 |
04/01/23 |
04/01/23 |
ASX - By Stock
|
28
|
10K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
CEO interview on Proactive Investors
|
|
whitefox9
|
15 |
6.0K |
5 |
09/12/22 |
09/12/22 |
ASX - By Stock
|
15
|
6.0K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: FDA Approves Early Feasibility Study for DurAVR THV System
|
|
whitefox9
|
47 |
18K |
5 |
28/11/22 |
28/11/22 |
ASX - By Stock
|
47
|
18K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: FDA Approves Early Feasibility Study for DurAVR THV System
|
|
whitefox9
|
47 |
18K |
8 |
28/11/22 |
28/11/22 |
ASX - By Stock
|
47
|
18K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Results Demonstrating Restoration of Normal Pre-Disease Flow
|
|
whitefox9
|
13 |
4.9K |
3 |
19/09/22 |
19/09/22 |
ASX - By Stock
|
13
|
4.9K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
AGM recording - enjoy
|
|
whitefox9
|
47 |
20K |
5 |
06/06/22 |
06/06/22 |
ASX - By Stock
|
47
|
20K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Successful Completion of Second First-In-Human Study
|
|
whitefox9
|
20 |
9.6K |
0 |
01/06/22 |
01/06/22 |
ASX - By Stock
|
20
|
9.6K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
A timeline going forward would be greatly appreciated
|
|
whitefox9
|
138 |
52K |
0 |
07/04/22 |
07/04/22 |
ASX - By Stock
|
138
|
52K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Wayne interview with The Market Herald
|
|
whitefox9
|
10 |
4.0K |
5 |
11/03/22 |
11/03/22 |
ASX - By Stock
|
10
|
4.0K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
whitefox9
|
115 |
40K |
2 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
115
|
40K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
whitefox9
|
115 |
40K |
15 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
115
|
40K
|
15
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
whitefox9
|
115 |
40K |
3 |
08/03/22 |
08/03/22 |
ASX - By Stock
|
115
|
40K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Ceasing to be a substantial holder
|
|
whitefox9
|
39 |
12K |
8 |
16/02/22 |
16/02/22 |
ASX - By Stock
|
39
|
12K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Proposal to Negotiate Non-Binding Letter of Intent - Merger
|
|
whitefox9
|
141 |
44K |
18 |
11/02/22 |
11/02/22 |
ASX - By Stock
|
141
|
44K
|
18
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Proposal to Negotiate Non-Binding Letter of Intent - Merger
|
|
whitefox9
|
141 |
44K |
34 |
09/02/22 |
09/02/22 |
ASX - By Stock
|
141
|
44K
|
34
|
|
ASX - By Stock
|
AVR |
Re:
News: AVR Anteris Technologies Says Co Has Received A Confidential, Non-Binding Proposal To...
|
|
whitefox9
|
57 |
15K |
1 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
57
|
15K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Interview with Wayne and Proactive Investors
|
|
whitefox9
|
122 |
35K |
1 |
03/02/22 |
03/02/22 |
ASX - By Stock
|
122
|
35K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Underwriting Agreement - AVRO Listed Options
|
|
whitefox9
|
15 |
5.0K |
5 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
15
|
5.0K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
AVR CEO Wayne Paterson interview about FIH TAVR results.
|
|
whitefox9
|
9 |
2.6K |
1 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
9
|
2.6K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
AVR CEO Wayne Paterson interview about FIH TAVR results.
|
|
whitefox9
|
9 |
2.6K |
1 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
9
|
2.6K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
AVR CEO Wayne Paterson interview about FIH TAVR results.
|
|
whitefox9
|
9 |
2.6K |
0 |
30/11/21 |
30/11/21 |
ASX - By Stock
|
9
|
2.6K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Change in substantial holding
|
|
whitefox9
|
7 |
2.0K |
0 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
7
|
2.0K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Change in substantial holding
|
|
whitefox9
|
7 |
2.0K |
1 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
7
|
2.0K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Key Animal Study for EFS Submission Completed
|
|
whitefox9
|
33 |
10K |
0 |
18/11/21 |
18/11/21 |
ASX - By Stock
|
33
|
10K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: DurAVR accepted into TCT Innovation session
|
|
whitefox9
|
31 |
9.6K |
4 |
21/10/21 |
21/10/21 |
ASX - By Stock
|
31
|
9.6K
|
4
|
|